Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Cotellic Cobimetinib hemifumarate 22.2mg equivalent to cobimetinib 20mg Film coated tablet Roche Products (NZ) Limited F Hoffmann-La Roche Limited, Basel, Switzerland
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Dysport Clostridium botulinum type A toxin haemagglutinin complex 300U Powder for injection Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics Ipsen Biopharm Limited, Wrexham, United Kingdom
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Dysport Clostridium botulinum type A toxin haemagglutinin complex 500U Powder for injection Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics Ipsen Biopharm Limited, Wrexham, United Kingdom
|
Product: Active Ingredient:
Dosage Form: New Zealand Sponsor: Manufacturer:
|
Glycophos Sodium glycerophosphate pentahydrate 306.1mg/mL equivalent to sodium glycerophosphate anhydrous 216mg/mL Concentrate for infusion Fresenius Kabi New Zealand Limited Fresenius Kabi Norge AS, Halden, Norway
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Zipzoc Zinc oxide 20%w/w Medicated dressing Smith & Nephew Limited Perstorp Pharma, Perstorp, Sweden Purna Pharmaceuticals NV, Puurs, Belgium
|
Dated this 11th day of February 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).